Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma

<p>All Supplementary Tables</p>

Salvato in:
Dettagli Bibliografici
Autore principale: Evangeline R. Jackson (15558808) (author)
Altri autori: Ryan J. Duchatel (15558811) (author), Dilana E. Staudt (15558814) (author), Mika L. Persson (15558817) (author), Abdul Mannan (15558820) (author), Sridevi Yadavilli (15558823) (author), Sarah Parackal (15558826) (author), Shaye Game (15558829) (author), Wai Chin Chong (15558832) (author), W. Samantha N. Jayasekara (15558835) (author), Marion Le Grand (15558838) (author), Padraic S. Kearney (15558841) (author), Alicia M. Douglas (15558844) (author), Izac J. Findlay (15558847) (author), Zacary P. Germon (15558850) (author), Holly P. McEwen (15558853) (author), Tyrone S. Beitaki (15558856) (author), Adjanie Patabendige (15558859) (author), David A. Skerrett-Byrne (15558862) (author), Brett Nixon (9587818) (author), Nathan D. Smith (15558865) (author), Bryan Day (15558868) (author), Neevika Manoharan (15558871) (author), Sumanth Nagabushan (15558874) (author), Jordan R. Hansford (15022992) (author), Dinisha Govender (15558877) (author), Geoff B. McCowage (15558880) (author), Ron Firestein (15558883) (author), Meegan Howlett (15558886) (author), Raelene Endersby (15558889) (author), Nicholas G. Gottardo (15558892) (author), Frank Alvaro (15558895) (author), Sebastian M. Waszak (15042965) (author), Martin R. Larsen (15558898) (author), Yolanda Colino-Sanguino (15558901) (author), Fatima Valdes-Mora (15558904) (author), Andria Rakotomalala (15558907) (author), Samuel Meignan (15558910) (author), Eddy Pasquier (15558913) (author), Nicolas André (15119506) (author), Esther Hulleman (15558916) (author), David D. Eisenstat (15558919) (author), Nicholas A. Vitanza (15122158) (author), Javad Nazarian (15558922) (author), Carl Koschmann (15558925) (author), Sabine Mueller (15042968) (author), Jason E. Cain (15558928) (author), Matthew D. Dun (15122218) (author)
Pubblicazione: 2025
Soggetti:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!